Where does Aerin Medical Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Aerin Medical Inc. ranks #5,734 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Aerin Medical Inc. hold?

Aerin Medical Inc. holds 59 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Aerin Medical Inc.'s Innovation Score?

Aerin Medical Inc. has an Innovation Score of 36.1 out of 100 (top 47% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Aerin Medical Inc. focus on?

Aerin Medical Inc.'s top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 53 patents, ranking #356 of 7,127 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Aerin Medical Inc.'s patent grant rate increasing or decreasing?

Aerin Medical Inc.'s recent grant velocity is -4% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Aerin Medical Inc.'s patents?

Aerin Medical Inc.'s patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Aerin Medical Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Aerin Medical Inc.

USPTO PatentsView assignee record - 59 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Aerin ranks #5,734 of 49,997 tracked US assignees by granted-patent volume, with 59 patents across 7 technology areas.

#5,734
of 49,997 US assignees by volume: Top 47%
by Innovation Score (36.1/100): 13.8
avg claims per patent: -4%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R5734 · US Corporation #5,734 · 59 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 59 grants
UPPER-Q #5,734/49,997
PHOTO-FINISH Accuvein
CPC-NARROW A61B · 7 areas
INNOV-THIN 36.1/100
CLAIMS-RICH 13.8 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT -4% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Accuvein, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Aerin’s 36.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 14.1 pts (39%) Velocity 4.3 pts (12%) Breadth 9.4 pts (26%) Claim depth 8.3 pts (23%)

Qualcomm Incorporated · highest

85
Aerin Medical · this assignee

36
Dyax · near

36
Magnolia White · near

36
Mako Rentals · near

36
WaveLight · near

36
3D Lighting… · lowest

7

What this shows Aerin's Innovation Score is 36.1/100 (top 47% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Aerin?

Each dot is one of Aerin’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Aerin’s own 13.8 claims/patent is at or below the 15.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Aerin vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Aerin's grants concentrate

Aerin Medical Inc. is a focused PatentsView assignee: 7 CPC subclasses with 89.8% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2019 (8 grants) versus a trough of 2 in 2024. By volume, Aerin sits between Arcturus Therapeutics, Inc. and Banjo Corporation.

Aerin's three-year grant acceleration

From 2019–2021 to 2022–2024, Aerin Medical Inc. moved from 20 to 13 grants (0.65x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Arcturus Therapeu…

59
Arris Technology

59
Auras Technology

59
Accuvein

59
Bauerfeind

59
Baylor Research I…

59
BP Exploration Op…

59
Banjo

59
Aerin Medical ◀

59

What this shows Aerin holds 59 patents at rank #5,738, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Aerin

By rank, the assignees closest to #5,738 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Aerin's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Aerin, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Aerin ranks #356 of 7,127 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (36 here).

Dyax Corp. 36 WaveLight GmbH 36 Magnolia White Corporation 36 Mako Rentals, Inc. 36

Similar claim depth

Nearest assignees by average claims per patent (13.8 here).

Lesaffre ET Compagnie 13.8 avg Solo Brands, LLC 13.8 avg European Molecular Biology Laboratory 13.8 avg Glenmark Pharmaceuticals S.A. 13.8 avg

Aerin's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Aerin Medical Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	8.5%
2016	6	10.2%
2017	3	5.1%
2018	4	6.8%
2019	8	13.6%
2020	8	13.6%
2021	4	6.8%
2022	6	10.2%
2023	5	8.5%
2024	2	3.4%
2025partial year	8	13.6%

Which technologies does Aerin Medical Inc. patent most?

A61B - DIAGNOSIS; SURGERY; Identification 53

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 48

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 48

F04C - Rotary-piston, OR Oscillating-piston, Positive-displacement Machines FOR Liquids ; Rotary-piston, OR Oscillating-piston, Positive-displacement Pumps 36

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 10

C12Y - Enzymes 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Aerin Medical Inc.'s patent record in context - here's where to go next.

Aerin Medical Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 89.8% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #5,734 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Aerin Medical Inc. against Arcturus Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.